Private company

Sirna Therapeutics

Biotechnology company

Sirna Therapeutics, Inc. was a San Francisco, California based biotechnology company that explored the use of RNA interference in human disease therapy.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

  • HeadquartersSan Francisco1

Sirna Therapeutics, Inc. was a San Francisco, California based biotechnology company that explored the use of RNA interference in human disease therapy.2

Corporate structure

Sirna Therapeutics is part of a group headed by Alnylam Pharmaceuticals. 24 entities, 18 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Alnylam Pharmaceuticals Camebridge, Massachusetts, United States
    • Sirna Therapeutics San Francisco
    • Alnylam (Bermuda) Ltd. Subsidiary · Bermuda
    • Alnylam Australia Pty Ltd. Subsidiary · Australia
    • Alnylam Austria GmbH Subsidiary · Austria
    • Alnylam Belgium SPRL/BVBA Subsidiary · Belgium
    • Alnylam Brasil Farmaceutica Ltda. Subsidiary · Brazil
    • Alnylam Canada ULC Subsidiary · Canada
    • Alnylam Europe AG Subsidiary · Germany
    • Alnylam France SAS Subsidiary · France
    • Alnylam Germany GmbH Subsidiary · Germany
    • Alnylam Italy Srl Subsidiary · Italy
    • Alnylam Japan KK Subsidiary · Japan
    • Alnylam Netherlands BV Subsidiary · Netherlands
    • Alnylam Pharmaceuticals Spain SL Subsidiary · Spain
    • Alnylam Securities Corporation Subsidiary · Massachusetts, United States
    • Alnylam Sweden AB Subsidiary · Sweden
    • Alnylam Switzerland GmbH Subsidiary · Switzerland
    • Alnylam Taiwan Co. Ltd. Subsidiary · Taiwan
    • Alnylam U.S. Holdings, Inc. Subsidiary · Delaware, United States
    • Alnylam U.S., Inc. Subsidiary · Delaware, United States
    • Alnylam UK Holdings Ltd. Subsidiary · United Kingdom
    • Alnylam UK Ltd. Subsidiary · United Kingdom
    • ALNYPT Unipessoal LDA Subsidiary · Portugal

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC. Each entity in the chart links to its source.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2